PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)
Status:
Active, not recruiting
First Received:
June 2, 2008
Information provided by:
Osiris Therapeutics
Sponsors and Collaborators:
Osiris Therapeutics
Juvenile Diabetes Research Foundation
Contacts:
/
Autologous Mesenchymal Stem Cell and Bone Marrow Stem Cell Infusion Combined With Hyperbaric Oxygen Therapy in Type 2 Diabetes Mellitus
Status:
Recruiting
First Received:
October 6, 2008
Information provided by:
Fuzhou General Hospital
Sponsors and Collaborators:
Fuzhou General Hospital
Contacts:
Jianming Tan, Professor ☎
008613375918000 ➔ doctortjm@yahoo.com
Stem Cell Therapy for Type 2 Diabetes Mellitus
Status:
Not yet recruiting
First Received:
June 10, 2010
Information provided by:
Cellonis Biotechnology Co. Ltd.
Sponsors and Collaborators:
Cellonis Biotechnology Co. Ltd.
Contacts:
/
Stem Cell Therapy for Type 1 Diabetes Mellitus
Status:
Not yet recruiting
First Received:
June 10, 2010
Information provided by:
Cellonis Biotechnology Co. Ltd.
Sponsors and Collaborators:
Cellonis Biotechnology Co. Ltd.
Contacts:
/
Intraarterial Infusion of Autologous Mesenchymal Stem Cells From Adipose Tissue in Diabetic Patients With Chronic Critical Limb Ischemia (CeTMAd/ICPD200)
Status:
Recruiting
First Received:
June 10, 2010
Information provided by:
Fundacion Progreso y Salud, Spain
Sponsors and Collaborators:
Fundacion Progreso y Salud, Spain
Carlos III Health Institute
Contacts:
Ana Cardesa
Intraarterial Infusion of Autologous Mesenchymal Stem Cells From Adipose Tissue in Diabetic Patients With Chronic Critical Limb Ischemia (CeTMAd/ICPD200)
Status:
Recruiting
First Received:
June 10, 2010
Information provided by:
Fundacion Progreso y Salud, Spain
Sponsors and Collaborators:
Fundacion Progreso y Salud, Spain
Carlos III Health Institute
Contacts:
Ana Cardesa ☎ 0034 955 01 9040
Human Adipose Derived Mesenchymal Stem Cells for Critical Limb Ischemia in Diabetic Patients
Status:
Recruiting
First Received:
March 25, 2008
Information provided by:
Fundacion Progreso y Salud, Spain
Sponsors and Collaborators:
dacion Progreso y Salud, Spain
Carlos III Health Institute
Contacts:
Inmaculada C Perez-Camacho, MD, PhD ☎ +34955693440 ➔ Ipercam06@gmail.com
Rafael J Ruiz-Salmerón, MD, PhD ☎ +34955693440 ➔ rjruizsalmeron@yahoo.es
Cotransplantation of Islet and Mesenchymal Stem Cell in Type 1 Diabetic Patients
Status:
Recruiting
First Received:
March 25, 2008
Information provided by:
Fuzhou General Hospital
Sponsors and Collaborators:
Fuzhou General Hospital
Contacts:
Jianming Tan, Professor ☎
008613375918000 ➔ tanjm156@yahoo.com.cn
Induced Wound Healing by Application of Expanded Bone Marrow Stem Cells in Diabetic Patients With Critical Limb Ischemia
Status:
Completed
First Received:
February 8, 2010
Information provided by:
Ruhr University of Bochum
Sponsors and Collaborators:
Ruhr University of Bochum
Contacts:
/
Umbilical Cord Mesenchymal Stem Cells Injection for Diabetic Foot
Status:
Not yet recruiting
First Received:
October 6, 2010
Information provided by:
Qingdao University
Sponsors and Collaborators:
Qingdao University
Contacts:
Jianxia Hu, MD ☎ 86-0532-82911676 ➔ qdyxyhjx@126.com
Hong Gao, MS ☎ 86-0532-82911676 ➔ honggaogloria@gmail.com
Comparison of Autologous Mesenchymal Stem Cells and Mononuclear Cells on Diabetic Critical Limb Ischemia and Foot Ulcer
Status:
Completed
First Received:
August 4, 2009
Information provided by:
Third Military Medical University
Sponsors and Collaborators:
Third Military Medical University
Contacts:
/
The Role of Lipoaspirate Injection in the Treatment of Diabetic Lower Extremity Wounds and Venous Stasis Ulcers
